Endpoints Webinars

Life sciences marketers work with long sales cycles and products that require market education — which make webinars one of the most essential tools in the biopharma demand generation toolbox.

Endpoints webinars are a turn-key solution — let us handle the audience generation, marketing, and tech.

Upcoming Webinars

From AI to IRA to GLP-1s: Unpacking the major healthcare trends at #JPM2025

Register Now

The pragmatic shift: Designing trials that fit the real world

Register Now

Accelerating drug discovery with an end-to-end imaging data management platform

Register Now

Accelerating discovery in targeted protein degradation: Innovative approaches to degrader screening

Register Now

past Webinars

Gene therapy assays: Achieving regulatory compliance with a unified immunogenicity strategy

watch Now

FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases

watch Now

Post-ESMO review: How molecular residual disease testing is transforming cancer care and drug development

watch Now

Mitigating risk in mRNA manufacturing when transitioning from preclinical to clinical

watch Now

Unlocking biotech’s potential: Strategies for navigating public and private market investments

watch Now

Visual biology AI neural network recognize disease signatures in cellular pathway visualizations

watch Now

Structural biology is advancing biotherapeutics design

watch Now

Leveraging post-marketing regulatory requirements to drive commercial value

watch Now

The power of antigen-specific TCR signatures in developing next-gen immunotherapies

watch Now

Optimizing clinical supply flexibility with demand-led strategies

watch Now

Viral vector manufacturing: Navigating complexities, finding solutions

watch Now

Lessons from the Real World: Journey from Claims to EHR Data in Real-World Evidence Generation

watch Now

CDMOs’ critical role in a rapidly evolving biopharma landscape

watch Now

ASCO24 Summary: Latest data on ctDNA as a patient selection and early efficacy marker in drug development

watch Now

Clinical trials agility: Tips for adapting to study changes and unexpected events

watch Now

Utilizing novel icIEF fractionation and mass spec for the charge characterization of biotherapeutics

watch Now

New ASCO data: Early detection with WGS-based ctDNA tracking up to 1800 variants

watch Now

Case study: Marketing to HCPs using data-based omnichannel segmentation

watch Now

Venture capital velocity: What’s driving renewed momentum in biotech

watch Now

How real-world research can streamline post-marketing studies in oncology

watch Now

Enabling Adaptive Clinical Trials through Integrated Development and Manufacturing Solutions

watch Now

Enhance your long-term cell & gene therapy success with pDNA manufacturing solutions

watch Now

Applying Real-World Data: Use cases and FDA guidance

watch Now

Navigating Policy, Funding, CMC and Regulatory Dynamics for Successful Orphan Drug Development

watch Now

Latest Data: How ctDNA can transform interventional trial design for GI cancers

watch Now

Leveraging large-scale mRNA biology data to advance disease understanding

watch Now

3 things every life sciences company should know before leveraging AI to generate real-world evidence

watch Now

Navigating the clinical AI landscape & charting your path to precision medicine

watch Now

The top 100 venture investors in biotech: Who’s in, what’s out

watch Now

7 questions gene therapy developers should ask their CDMO (and what they will ask you!)

watch Now

Untapped potential: Integrating MRD testing to track diffuse large B-cell lymphoma in clinical trials and in the clinic

watch Now

Post-SABCS summary & year in review: ctDNA in drug development for breast cancer

watch Now

Advertising with Endpoints: Our publisher's take on success stories of 2023

watch Now

Biopharma communications: Audience engagement strategies to rebuild confidence

watch Now

Advancing Non-Small Cell Lung Cancer drug discovery and treatment with clinicogenomics

watch Now

The Endpoints 100 survey: What are industry execs saying about 2024?

watch Now

CRISPR genome editing solutions from discovery to clinic

watch Now

High Lp(a): The unmet need and value of an expansive drug development landscape

watch Now

Data-based strategies for successful digital health technology (DHT) clinical trials

watch Now

State of the union for advanced therapies

watch Now

Can oncolytic viruses make a comeback?

watch Now

Data: The unsung hero of AI

watch Now

Scalable data strategies for scientific AI-enabled breakthroughs

watch Now

Oncology case studies: How two life sciences companies applied real-world evidence to drive innovation

watch Now

Unlocking insight from health data with healthcare-specific AI that thinks like a physician

watch Now

Actionable data: Challenges, solutions and case studies across pharma research

watch Now

Raising capital: A new playbook for a new era in biotech

watch Now

Evolving DNA-Encoded Library (DEL) technology to meet drug discovery needs

watch Now

A roadmap to earlier efficacy predictors and drivers in cell therapy development

watch Now

Re-activating the immune system against cancer: The next I-O revolution

watch Now

Harnessing cell power: Targeted protein degraders’ potential in combating disease

watch Now

Targeted Protein Degraders – Key Strategies to Maximize VC Funding and Clinical Success

watch Now

De-risking clinical development and driving therapeutic innovation: The power of RWD from EHRs

watch Now

Drug research institutes put dealmaking on the front burner

watch Now

Rise of mRNA manufacturing

watch Now

Cryo-electron microscopy is revolutionizing rational drug discovery pipelines

watch Now

The future of cell therapy manufacturing has arrived

watch Now

How to plan for fill finish manufacturing success

watch Now

Applying novel pairing technology for more diverse antibody discovery

watch Now

How immune repertoire sequencing is addressing unmet needs in multiple sclerosis drug development

watch Now

Advancing health equity in clinical trials by addressing the financial burden

watch Now

Clinical trials in China: unlocking the potential of advanced therapies

watch Now

The catastrophe of traditional statistical learning

watch Now

Alzheimer’s disease: Using deep human biology learning to guide next-generation treatments

watch Now

Harnessing the power of antigen specific T-cell responses to improve vaccine development

watch Now

The future of cell therapy development and delivery

watch Now

How biophysics can change the receive characteristics of tumors

watch Now

Pharma can target ultra-rare conditions — the next step is financing them

watch Now

Post-ASCO Summary: ctDNA as a patient selection and early efficacy marker in drug development

watch Now

Accelerating all phases of the immuno-oncology drug development pipeline via immunosequencing

watch Now

Transforming clinical research: Scaling real-world data across diseases with expert-led AI

watch Now

Maximizing efficiency in your next state-of-the-art facility build

watch Now

Life sciences dealmaking faces more antitrust scrutiny

watch Now

Blood cancer breakthroughs: what’s next for underserved markets

watch Now

The connected lab: maximizing the intersection of science and data

watch Now

How to assess the quality of AI output when structuring unstructured medical data

watch Now

ASCO '23 Preview: Key trials with high clinical and commercial impact

watch Now

Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges

watch Now

The AI drug-discovery revolution: How NYC is prepared to lead

watch Now

Hungry for knowledge? Set the table for HCP and patient engagement

watch Now

When to call it quits: VCs making tough decisions in a tough market

watch Now

Exposing hidden targets within the mRNA regulation space

watch Now

A novel 3D approach to imaging gene therapy expression and vector biodistribution

watch Now

CAR-T beyond cancer

watch Now

Beyond AAV: Prepare for the next generation of advanced therapy delivery

watch Now

FDA Inspection Readiness: Before, During, and After

watch Now

Big cardio is back in focus

watch Now

Pairing quality genomic data with longitudinal patient records

watch Now

New data: ctDNA as a prognostic and predictive biomarker in early-stage gastrointestinal cancers

watch Now

Keeping pace with the evolving global landscape in vaccine development

watch Now

Let’s talk: Moving CGTx clinical development forward in 2023

watch Now

Beyond vaccines: Where mRNA technology goes next

watch Now

Biopharma smart factories: Achieving next-generation performance

watch Now

The top 100 biotech VCs: Who’s staying at the table and what do they want now?

watch Now

Small molecule orphan drugs: Status quo, challenges, and perspectives

watch Now

Expediting drug product development and commercialization in global markets with global filing strategies

watch Now

Three data resolutions every biotech needs to set — and stick to — in 2023

watch Now

Decentralized trial solutions for complex clinical trials

watch Now

Endpoints' most popular content this year – an exclusive view for marketers

watch Now

New data: Predict breast cancer treatment response and recurrence risk with ctDNA

watch Now

Is Alzheimer’s R&D finally moving past the crossroads?

watch Now

Digital therapeutics: Software is now entering mainstream therapeutic care

watch Now

State of the union for advanced medicines

watch Now

Why oncology needs more than MRD

watch Now

Weird and wonderful case studies: Real-world solutions for unexpected bioanalytical challenges

watch Now

How will AI transform the future of medicine?

watch Now

Patient need for novel therapies in ROS1 fusion-positive non-small cell lung cancer

watch Now

Navigating industry challenges to drive sustainable Plasmid DNA strategies

watch Now

The vaccine R&D revolution goes global

watch Now

Overcoming manufacturing challenges for advanced medicines

watch Now

Lessons learned in bringing novel options for rare liver diseases to patients and families

watch Now

Making the case for digital transformation in biotech R&D

watch Now

Gene therapy roundup—what to know now from the lab to the FDA

watch Now

Accelerate drug development with clinicogenomic RWE

watch Now

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

watch Now

Advanced dosage forms: Tackling drug delivery challenges & addressing patient needs

watch Now

The clinical trial recruitment crisis hits home

watch Now

The evaluation of pan-cancer and oncoReveal™ CDx panels to support localized NGS testing

watch Now

Project Optimus: Early-stage haste can lead to waste

watch Now

A journey without a map: lessons in building an oncology powerhouse where innovation thrives

watch Now

Changing the paradigm for colorectal cancer: Clinical practice & drug development

watch Now

A crisis in rare disease: How the current investment landscape is stifling rare disease development

watch Now

Why can’t we agree on how to define digital twins in healthcare?

watch Now

Hit discovery with self-service DNA-encoded Libraries

watch Now

Parkinson’s R&D: Have we finally reached a turning point?

watch Now

Integrated clinical development and supply: Breaking down the early-development journey of a small molecule

watch Now

Identify and quantify point mutations in circulating tumour DNA: The ddPCR approach™

watch Now

Planning for CGT commercialization: It starts sooner than you think

watch Now

Developing optimal biomarkers for cancer immunotherapy

watch Now

Biology's modern LIMS for labs of the future

watch Now

Pain R&D: Plenty of pain to go around, but who’s making gains?

watch Now

Advanced plasmid technology: improving safety and performance

watch Now

How could an open access DNA-encoded library benefit your research?

watch Now

New data: How ctDNA is evolving oncology patient management and drug development

watch Now

Evolution of cell & gene therapy in China: the case for universal CAR-T

watch Now

Public markets' impact on manufacturing advanced therapies

watch Now

Mission critical: Cybersecurity

watch Now

New biomarkers are remapping the world of cancer studies

watch Now

Double your development speed: a new approach to viral vector design

watch Now

Accelerating first-in-class and best-in-class programs using a large-scale digital chemistry strategy

watch Now

Rethinking market access: Delivering on the promise of therapeutic innovation

watch Now

Applying machine learning to increase clinical trial efficiency: a regulatory journey

watch Now

Building a digital foundation for patient-centric trials

watch Now

Data’s influence early in the commercialization process

watch Now

How to create a stand-out customer experience for cell and gene therapies

watch Now

Solving complex immunogenicity challenges

watch Now

R&D changemakers: Building Resilience’s digital infrastructure for a modern R&D team

watch Now

How can real-world clinico-genomics data optimize drug development?

watch Now

The R&D challenge: What are the best practices in drug development today?

watch Now

The role of Parkinson’s Disease biomarkers in drug development clinical trials

watch Now

Metabolomics in drug discovery: The missing piece for multi-omics data

watch Now

Making innovation matter by ensuring access to cancer care

watch Now

The new psychedelic age in biotech

watch Now

The phase 1 trial setup toolbox

watch Now

Planning for the commercialization of advanced therapies

watch Now

AI faces its moment of truth

watch Now

Diagnostics from digital pathology: an AI solution to accelerate precision medicine

watch Now

Different approaches to process development and manufacturing in gene therapy

watch Now

How can biopharma deliver on the promise of precision medicine?

watch Now

The pillars of research in 2035

watch Now

The top 100 VCs in biotech 2022

watch Now

Did you know Australia does toxicology?

watch Now

Navigating your biopharma drug candidate through early and mid-stage clinical trials

watch Now

The checkpoint debate is about to get real

watch Now

Ensuring sample integrity from collection to analysis

watch Now

CQV strategies that increase speed-to-market for gene therapy

watch Now

Enterprise R&D technology adoption case study: Genentech

watch Now

Checkpoint inhibitors: the gut microbiome’s role in anti-tumor response

watch Now

Using external data to accelerate randomized controlled trials without introducing bias

watch Now

State of the union for advanced medicines

watch Now

CQV strategies to optimize cell therapy manufacturing

watch Now

Innovations in clinical trial design with ctDNA MRD

watch Now

Developing the next big vaccine technologies

watch Now

Running decentralized trials at scale

watch Now

mHealth innovation: identifying the best patient-centered technology for your trial needs

watch Now

How biotechs have found success with University of Florida technologies

watch Now

Changing the game: an examination of cutting-edge novel oncology screening tools

watch Now

Scaling up a gene therapy manufacturing facility

watch Now

A new class of startups is scouting for deals - on both sides of the Pacific

watch Now

DEL like never before - 4th generation of DEL kits

watch Now

Driving efficiencies through virtual trial solutions in Asia Pacific

watch Now

After a decade of consolidation, who rules the CRO roost?

watch Now

Concept to dosing: Challenges in new orphan drugs

watch Now

Is the AI revolution empowering the scientist?

watch Now

How Regeneron scaled its cloud to support millions of samples a year

watch Now

Can changing one step change everything? Replacing your polishing step with a single-use solution

watch Now

Pricing strategies for advanced therapies

watch Now

HQ plasmid DNA: a case for phase dependent approaches to manufacturing

watch Now

Non-clinical and clinical pathways for rapid vaccine development in Australia

watch Now

Leading with data: tumor-informed ctDNA testing across cancer types

watch Now

After the pandemic, antibody R&D remains key

watch Now

Strategies for building a cell therapy manufacturing facility

watch Now

The neurosciences comeback: After a lengthy chill, Big Pharma is warming back up to neuro

watch Now

Recent key advances in autologous stem cell-derived therapies

watch Now

Expedited clinical development strategies for China

watch Now

Protein degradation: Looking back and moving forward

watch Now

Enrolling a global study ahead of schedule (during a pandemic)

watch Now

The big platform plays have been in vogue. But for how long?

watch Now

Essential strategies for gene therapy - from assay development to CDx commercialization

watch Now

Innovation in drug product manufacturing: how do we bring new therapies to patients faster?

watch Now

Life science SPACs – the future of IPOs/crossover investing? A look at 2021/2022

watch Now

Kantar Health on the most impactful trials at ASCO

watch Now

Reinventing Harvest Technology: Single-stage chromatography clarification for recombinant protein therapeutic manufacturing

watch Now

Reengineering CAR-T for solid tumors

watch Now

Informed by the tumor: new data on the power of a personalized ctDNA assay

watch Now

Deconvoluting inflammation and immunology for clinical trials

watch Now

How scalable and intensified is your CAR-T process?

watch Now

Improving endpoint selection in Alzheimer’s disease trials

watch Now

Are we ready for the medicines of tomorrow? Creating the infrastructure for the era of genomic medicine

watch Now

Plasmid DNA Insights: Expanded focus on CMC in gene & cell therapy development

watch Now

Developing and using digital biomarkers

watch Now

Transformative approaches to clinical development: Scaling adoption across the industry

watch Now

Realizing the full potential of clinicogenomics

watch Now

Hot topics in Immunoassay Bioanalysis - navigating the immunogenicity and biomarker requirements for clinical trials

watch Now

The Great Debate: Internal vs. external manufacturing for advanced therapies

watch Now

Predict placebo response using patient psychology to increase trial power

watch Now

Can sponsors collect data in Expanded Access (EAPs) and Named Patient Programs (NPPs)?

watch Now

Clinical trial diversity in the Covid-19 era — are we seeing a paradigm shift?

watch Now

The benefits of running clinical trials in China

watch Now

Where does your organization sit on the omnichannel maturity curve?

watch Now

Flattening the 'valley of death:' New tools in the hunt for better preclinical R&D

watch Now

Repurposing drugs for new indications: benefits and challenges

watch Now

Leveraging APAC partnerships to de-risk clinical trials

watch Now

Patient-First R&D: Why the patient experience should be at the center of clinical trial design

watch Now

Navigating the path to the clinic and beyond for gene therapies

watch Now

Beyond AAV 1.0

watch Now

Enabling multidimensional tumor immunogenomics for advancing biomarker discovery

watch Now

Breakthrough Technologies to Accelerate Biologic Drug Discovery, Cell Line Development and Biomanufacturability

watch Now

How the World’s First Biolabs Client Portal GALEXI™ Delivers Real-Time Study Management for Biotechs

watch Now

The Patient Voice in Rare Disease Research

watch Now

Redefining conditioning for a new era of gene therapy

watch Now

DEL Kits Special Event: A New Method of Hit Discovery

watch Now

Optimizing Direct-to-Patient Clinical Supply for Decentralized Clinical Trials

watch Now

Amgen’s BiTE® Platform and the Next Frontier in Immuno-Oncology

watch Now

Innovation in Clinical Research: AI-based Drug Development Tools and the Regulatory Landscape

watch Now

R&D in an age of Covid-19: Tackling the key issues around starting, or restarting an early-stage study

watch Now

Solving hard go-to-market challenges

watch Now

New Platform for Target-to-Hit: From Fragment Screen to Structure-based Drug Discovery

watch Now

Introduction to Self-Service DNA-Encoded libraries (DELs)

watch Now

Keeping Pace with Big Pharma - On A Start Up Budget

watch Now

Putting AI in R&D

watch Now

Managing Global Studies with Regional Partners

watch Now

Faster, More Efficient Trials: Novel Trial Designs using Digital Twins

watch Now

Why Australia is the World’s Leading Early Phase Destination – Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs

watch Now

The Transformation of Clinical Trial Design and Operations: A Panel Discussion on COVID-19 as a Catalyst for Decentralized Trials

watch Now

AI, Digital Twins, and the Future of Clinical Research

watch Now

When cell and gene therapies surge to market, how resilient will your cell sourcing infrastructure be?

watch Now

The Australian Early Phase Biosimilars Clinical Trial Landscape - How Agilex Biolabs and Nucleus Network Work Together

watch Now

The FDA and Covid-19: New rules for the R&D road

watch Now

Novel oncology trial designs with a personalized ctDNA assay

watch Now

Derisking orphan drug programs in 2020 and beyond

watch Now

A Clinical Investigator’s Perspective: Novel Oncology Therapy During & Beyond the COVID Pandemic

watch Now

Home Nursing Support for Clinical Trials

watch Now

Running First-in-human and Vaccines Studies in Australia

watch Now

How Easy is it to Move your Clinical Trials to Australia?

watch Now

Utilizing the immunoSEQ Assay in Clinical Trials

watch Now

The Covid-19 challenge: Keeping the supply chain intact

watch Now

Endpoints Editor John Carroll's Covid - 19 webinar series

watch Now

Dealmaking in a time of coronavirus

watch Now

Advancing Oncology Clinical Trials in Asia-Pacific

watch Now

Asia-Pacific – a Global hub for Hepatology Clinical Trials

watch Now

Perspectives on Partnering Post-Pandemic

watch Now

Clinical Trial Continuity in Asia-Pacific during the COVID-19 Pandemic

watch Now

The Australian Advantage: De-risk your early phase trials

watch Now

Rapid Deployment of Remote Trials During Containment

watch Now

RWD for R&D: Examples from Immunology, Rheumatology and Other Chronic Diseases

watch Now

Designing a turnkey orphan drug program

watch Now

The do’s and don’ts of managing a pivotal gene therapy trial

watch Now

You've got that coveted accelerated regulatory pathway. Now what?

watch Now

Developing better assays for biopharma with a CRO partner

watch Now

Are you really ready for your end of phase 2 meeting?

watch Now

How to run a Digital Trial and reduce time in development by 50%

watch Now

Improving Clinical Trial Quality with Best Practices for E-Clinical Technology

watch Now

Developing a digital therapeutics trial

watch Now

The Experts: Real World Endpoints

watch Now

Designing Next-Gen Oncology Trials

watch Now

ctDNA as a biomarker for monitoring treatment response and molecular recurrence in early-stage and metastatic cancers

watch Now

How to get the most out of your Phase I biologic study

watch Now

The Alzheimer's Trials of the Future

watch Now